Chemed Stock News

Thermo Fisher's (TMO) ReadyCheckGo program will enable Texas schools to have the options for fast, reliable testing to identify and limit the spread of COVID-19 quickly.

Nisa Investment Advisors LLC trimmed its position in shares of Chemed Co. (NYSE:CHE) by 13.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,134 shares of the companys stock after selling 1,300 shares during the period. Nisa Investment Advisors []

Chemed (NYSE:CHE) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research note issued on Friday, Zacks.com reports. The firm currently has a $500.00 price objective on the stock. Zacks Investment Researchs price target indicates a potential upside of 5.12% from the stocks current price. According to Zacks, []

Abbott (ABT) is registering strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.

The Zacks Analyst Blog Highlights: Abbott Laboratories, West Pharmaceuticals Services, Baxter International and Chemed Corp

Quest Diagnostics (DGX) offers Targeted Lung Panel Test at 2,200 conveniently located patient service centers across the United States.

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2021 Virtual Home Care Conference on Tuesday, December 7, 2021, at 11:00 AM (ET).

Zacks Investment Research upgraded shares of Chemed (NYSE:CHE) from a hold rating to a buy rating in a research report sent to investors on Friday morning, Zacks.com reports. The brokerage currently has $524.00 price objective on the stock. According to Zacks, Chemed ended the third quarter of 2021 on a bullish note with better-than-expected earnings [] The post Zacks Investment Research Upgrades Chemed (NYSE:CHE) to Buy appeared first on ETF Daily News .

Chemed (NYSE:CHE) was upgraded by Zacks Investment Research from a hold rating to a buy rating in a research report issued on Friday, Zacks.com reports. The brokerage currently has a $524.00 price target on the stock. Zacks Investment Researchs target price would suggest a potential upside of 8.42% from the companys previous close. According to []

Capital Insight Partners LLC grew its position in Chemed Co. (NYSE:CHE) by 6.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,973 shares of the companys stock after buying an additional 484 shares during the quarter. Capital Insight []

State of Alaska Department of Revenue decreased its stake in shares of Chemed Co. (NYSE:CHE) by 33.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 5,927 shares of the companys stock after selling 3,023 shares during the quarter. State of Alaska Department of Revenues []

The American Association of Individual Investors (AAII) publishes monthly tips for members on-line. Their November Journal featured these thirty Buffett-worthy candidates by one of Buffett's closest f